Morgan Stanley (NYSE:MS) analyst Nigel Dally maintained a Buy rating on Aflac Incorporated (NYSE:AFL) on Thursday, setting a price target of $58, which is approximately 13.33% above the present share price of $51.18.
Dally expects Aflac Incorporated to post earnings per share (EPS) of $1.36 for the second quarter of 2021.
The current consensus among 8 TipRanks analysts is for a Hold rating of shares in AFLAC, with an average price target of $48.5.
The analysts price targets range from a high of $58 to a low of $44.
In its latest earnings report, released on 12/31/2020, the company reported a quarterly revenue of $6 billion and a net profit of $0. The company's market cap is $35.19 billion.
According to TipRanks.com, Morgan Stanley analyst Nigel Dally is currently ranked with 4 stars on a 0-5 stars ranking scale, with an average return of 18.3% and a 63.41% success rate.
Georgia-based Aflac, Inc. was founded in 1955. The company provides supplement health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S.